ADVERTISEMENT

Abbott India Q2 Review - Key Therapies Report Robust Sales Improvement; Positive Outlook: Axis Securities

Abbott India Q2 Review - Key Therapies Report Robust Sales Improvement; Positive Outlook: Axis Securities

A biologist uses an Architect ci4100 automated analyzer manufactured by Abbott Laboratories. (Photographer: Alessia Pierdomenico/Bloomberg)
A biologist uses an Architect ci4100 automated analyzer manufactured by Abbott Laboratories. (Photographer: Alessia Pierdomenico/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More